Fistula News and Research

RSS
A Fistula is an abnormal opening or passage between two organs or between an organ and the surface of the body. Fistulas may be caused by injury, infection, or inflammation, or may be created during surgery.
A rare diagnosis leads to successful treatment for patient with unusual vascular condition

A rare diagnosis leads to successful treatment for patient with unusual vascular condition

Work in progress on medicine for treatment of ulcerative colitis

Work in progress on medicine for treatment of ulcerative colitis

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

Noninvasive radiation therapy offers new hope for patients with high-risk heart arrhythmias

Radiation therapy reduces episodes of deadly rapid heart rhythm

Radiation therapy reduces episodes of deadly rapid heart rhythm

One-fifth of U.S. surgeons still 'overusing' riskier method to create kidney dialysis access, study finds

One-fifth of U.S. surgeons still 'overusing' riskier method to create kidney dialysis access, study finds

A new approach to predict complications after surgery for patients with larynx cancer

A new approach to predict complications after surgery for patients with larynx cancer

Experts in coloproctology will unite to promote global collaboration at 14th Annual ESCP conference

Experts in coloproctology will unite to promote global collaboration at 14th Annual ESCP conference

Therapeutic endoscopy has an expanding role in the treatment of IBD

Therapeutic endoscopy has an expanding role in the treatment of IBD

Non-surgical fistula creation system Ellipsys becomes key focus of attention at CiDA

Non-surgical fistula creation system Ellipsys becomes key focus of attention at CiDA

Study finds link between Medicaid expansion and lower death rates among dialysis patients

Study finds link between Medicaid expansion and lower death rates among dialysis patients

New approach using 'cellular dust' offers hope for regenerative medicine

New approach using 'cellular dust' offers hope for regenerative medicine

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

FDA grants marketing authorization for use of two catheter-based devices in hemodialysis patients

FDA grants marketing authorization for use of two catheter-based devices in hemodialysis patients